Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Columbus › NPI 1376106021
Lab

Clariti Diagnostics Laboratories

Clariti Diagnostics Laboratories was paid $173K by Medicaid between Oct 2020 and Jul 2022, across 3 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

33Billing provider infoCLARITI DIAGNOSTICS LABORATORIES
COLUMBUS, OH 43235
33aNPI1376106021assigned 04/18/2019
28Total paid$173K
24GClaims5,193
24DCodes billed3
24AFirst – last monthOct 2020 – Jul 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#65 of 116
Median peer was paid$313K
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020192$16K
20214,000$127K
20221,001$30K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 74% 2,356 2,177 $128K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 18% 1,951 1,833 $31K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7.6% 886 829 $13K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLANDAU, JOSEPH (CEO)